The federal government is taking a new approach to overseeing one of the country's fastest-growing healthcare programs.
Chad Hatfield, Pharm.D., of UC Davis Health, says rebate model readiness starts with a spend review and data that pharmacy ...
It’s the second time the HHS has tried to kickstart a 340B rebate program — and the second time hospitals have sued to block ...
Drugmakers want a say in court to defend a rebate pilot in the 340B drug discount program that hospitals are trying to stop.
A proposed federal drug-discount overhaul could quietly funnel billions in new borrowing demand toward the banks already holding hospital credit lines, and the lenders best positioned to profit may ...
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to intervene in the lawsuit challenging the ...
A controversial program to subsidize safety-net hospitals’ drug spending “has expanded beyond its original intent,” ...
In response to news in the 340B Report last week that was highly critical of the drug industry's noncompliance with compulsory elements of the 340B drug pricing program, AIDS Healthcare Foundation ...
On behalf of our nearly 5,000 member hospitals, health systems and other healthcare organizations, including more than 2,000 hospitals and health systems that participate in the 340B Drug Pricing ...
A small, well-intended discount for safety net hospitals became a large institutional subsidy with expensive unintended ...
The Massachusetts House of Representatives passed a $2.354 billion supplemental budget Wednesday aimed at closing out the ...
HRSA has approved implementation plans for 10 manufacturers participating in its revised 340B Rebate Model Pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results